McKesson (MCK) reported fiscal Q4 adjusted earnings late Thursday of $10.12 per diluted share, up from $6.18 a year earlier.
Analysts polled by FactSet expected $9.83.
Revenue for the quarter ended March 31 rose to $90.82 billion from $76.36 billion a year earlier.
Analysts expected $94.30 billion.
For its fiscal 2026, the company is projecting adjusted EPS of $36.75 to $37.55. Analysts are looking for $36.81.
McKesson on Thursday also disclosed plans to spin off its Medical-Surgical Solutions unit into a stand-alone company, stating it will provide further details on the timing and structure of the separation as the process advances.
The company's shares were up over 2% in recent after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.